EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants

Julian U G Wagner, Denisa Bojkova, Mariana Shumliakivska, Guillermo Luxán iD, Luka Nicin, Galip S Aslan, Hendrik Milting, Joshua D Kandler, Andreas Dendorfer, Andreas W Heumueller, Ingrid Fleming, Sofia-Iris Bibli und 6 weitere

Basic Research in Cardiology · 2021-12 · 116 (1)

DOI: 10.1007/s00395-021-00882-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 05.07.2021. Verfasst von Julian U G Wagner und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Willy Pitzer Foundation, Johann Wolfgang Goethe-Universität, Frankfurt am Main.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelial cells from different vascular beds including umbilical vein endothelial cells, coronary artery endothelial cells (HCAEC), cardiac and lung microvascular endothelial cells, or pulmonary arterial cells were inoculated in vitro with SARS-CoV-2. Viral spike protein was only detected in HCAECs after SARS-CoV-2 infection but not in the other endothelial cells tested. Consistently, only HCAEC expressed the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2), required for virus infection. Infection with the SARS-CoV-2 variants B.1.1.7, B.1.351, and P.2 resulted in significantly higher levels of viral spike protein. Despite this, no intracellular double-stranded viral RNA was detected and the supernatant did not contain infectious virus. Analysis of the cellular distribution of the spike protein revealed that it co-localized with endosomal calnexin. SARS-CoV-2 infection did induce the ER stress gene EDEM1, which is responsible for clearance of misfolded proteins from the ER. Whereas the wild type of SARS-CoV-2 did not induce cytotoxic or pro-inflammatory effects, the variant B.1.1.7 reduced the HCAEC cell number. Of the different tested endothelial cells, HCAECs showed highest viral uptake but did not promote virus replication. Effects on cell number were only observed after infection with the variant B.1.1.7, suggesting that endothelial protection may be particularly important in patients infected with this variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin-Converting Enzyme 2CalnexinCells, CulturedEndoplasmic ReticulumEndoplasmic Reticulum StressEndothelial CellsHost-Pathogen InteractionsHumansMembrane ProteinsReceptors, VirusSARS-CoV-2Spike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

ER stressEndothelial cellsSARS-CoV-2Virus trapping

Substanzen

CANX protein, humanEDEM1 protein, humanMembrane ProteinsReceptors, VirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2CalnexinACE2 protein, humanAngiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurt, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main, Frankfurt, Germany.
  • Cardiopulmonary Institute (CPI), Frankfurt, Germany.
  • Institute of Medical Virology, University Frankfurt, Frankfurt, Germany.
  • Clinic for Thoracic and Cardiovascular Surgery, Bad Oeyenhausen, Germany.
  • Walter-Brendel-Centre, Hospital of the Ludwig-Maximilians-University München, Munich, Germany.

ORCID-Profile: Guillermo Luxán

Förderung

  • Deutsche Forschungsgemeinschaft
  • Willy Pitzer Foundation
  • Johann Wolfgang Goethe-Universität, Frankfurt am Main

Zitieren

APA

Wagner, J. U. G., Bojkova, D., Shumliakivska, M., Luxán, G., Nicin, L., Aslan, G. S., Milting, H., Kandler, J. D., Dendorfer, A., Heumueller, A. W., Fleming, I., Bibli, S. I., Jakobi, T., Dieterich, C., Zeiher, A. M., Ciesek, S., Cinatl, J., & Dimmeler, S. (2021). Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Research in Cardiology, 116(1). https://doi.org/10.1007/s00395-021-00882-8

Vancouver

Wagner JUG, Bojkova D, Shumliakivska M, Luxán G, Nicin L, Aslan GS, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Research in Cardiology. 2021;116(1). doi:10.1007/s00395-021-00882-8

BibTeX
@article{Wagner2021,
  author = {Wagner, Julian U G and Bojkova, Denisa and Shumliakivska, Mariana and Luxán, Guillermo and Nicin, Luka and Aslan, Galip S and Milting, Hendrik and Kandler, Joshua D and Dendorfer, Andreas and Heumueller, Andreas W and Fleming, Ingrid and Bibli, Sofia-Iris and Jakobi, Tobias and Dieterich, Christoph and Zeiher, Andreas M and Ciesek, Sandra and Cinatl, Jindrich and Dimmeler, Stefanie},
  title = {Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants},
  journal = {Basic Research in Cardiology},
  year = {2021},
  volume = {116},
  number = {1},
  doi = {10.1007/s00395-021-00882-8}
}
Kostenlos starten →